Kliniken &… Institute Infektiologie Medizinische… Diagnostik / Forschung… Forschung Research Dalpke

Research Group Dalpke

Group Leader: Prof. Dr. med Alexander Dalpke

RESEARCH INTERESTS

The focus of my research is infection and immunity. Current work centers on two topics:

1. We are studying the recognition of microbial nucleic acids by pattern recognition receptors. We try to elucidate principles that enable Toll-like receptors to differentiate foreign, microbial from self nucleic acids. We address the importance of RNA modifications on TLR activation, specifically focusing on 2’-O-methyl modifications. Moreover we studyand the importance of RNA processing on immune stimulation with running projects on RNase 6 and 7. Finally,we are also interested in longterm effects of bacterial encounter on innate immune cells, a condition that has been termed trained immunity.

2. A second project area studies polymicrobial infections by means of next generation sequencing. We focus on patients suffering from cystic fibrosis (CF) but also use the technique to explore microbiome changes in other diseases. In CF we aim to analyze microbiome alterations in early childhood as well as during exacerbation and focus on interactions of commensal and pathogenic bacteria. Specifically we try to elucidate to what extent and how commensal bacteria affect growth and inflammation by classical pathogens. Currently we are focusing on the effects of short chain fatty acids.

 

Publications

Funding: DFG,, TRR156, TRR319, Mukoviszidose e.V.


 

Cells of the innate immune system recognize conserved microbial structures, so called pathogen-associated molecular patterns (PAMPs) by pattern recognition receptors. Among these receptors Toll-like receptors (TLR) 3, -7, -8, -9 and -13 recognize nucleic acids of viral, bacterial or synthetic origin. However, the exact mechanisms of nucleic acid recognition and the differentiation between foreign (dangerous) and self (usually harmless) are still only known partially. Work of our own could show (1) that bacterial RNA represents a PAMP recognized by various immune cells. We could also show that TLR13 is a murine receptor for bacterial RNA. (2) We work onposttranscriptional RNA modifications and their role role for self/non-self discrimination. We identified 2’-O-methylation as a modification that inhibits TLR7 and 8 stimulation. This naturally occurring RNA modification can be regulated under stress within bacteria thus potentially contributing to immune evasion. (3) Recent projects analyze the role of RNases in the process of TLR8 stimulation, as the receptor is activated by RNA breakdown products instead of full length RNA. We show that RNA processing by RNase6 is a prerequisite and critical for RNA-TLR interactions in monocytes. Of note, RNA modifications and RNA degradation act together. An ongoing project addresses the importance of RNase 7 for RNA recognition in the interplay of skin cells and monocytes.

Selected publications

Nunes IV*, Breitenbach L*, Pawusch S, Eigenbrod T, Ananth S, Schad P, Fackler OT, Butter F, Dalpke AH, Chen LS (2024): Bacterial RNA sensing by TLR8 requires RNase 6 processing and is inhibited by RNA 2’O-methylation. EMBO Rep, doi.org/10.1038/s44319-024-00281

Galvanin A, Vogt LM, Grober A, Freund I, Ayadi L, Bourguignon-Igel V, Bessler L, Jacob D, Eigenbrod T, Marchand V, Dalpke A, Helm M, Motorin Y (2020): Bacterial tRNA 2′-O-methylation is dynamically regulated under stress conditions and modulates innate immune response. Nucl Acid Res, 48(22): 12833-12844. doi: 10.1093/nar/gkaa1123

Hafner A, Kolbe U, Freund I, Castiglia V, Kovarik P, Poth P, Herster F, Weigand MA, Weber AN, Dalpke AH and Eigenbrod T (2019): Crucial role of nucleic acid sensing via endosomal Toll-like receptors for the defense of Streptococcus pyogenes in vitro and in vivo. Front Immunol, 10:198.doi: 10.3389/fimmu.2019.00198

Eigenbrod T and Dalpke AH (2015): Bacterial RNA: An Underestimated Stimulus for Innate Immune Responses. J Immunol 195(2): 411-8

Eigenbrod T, Pelka K, Latz E, Kreikemeyer B and Dalpke AH (2015): TLR8 Senses Bacterial RNA in Human Monocytes and Plays a Nonredundant Role for Recognition of Streptococcus pyogenes. J Immunol. 195(3): 1092-1099, doi: 10.4049/jimmunol.1403173 

Hidmark A, von Saint Paul A, Dalpke AH (2012): Cutting Edge: TLR13 is a receptor for bacterial RNA. J Immunol. 189(6):2717-21

Gehrig S, Eberle ME, Botschen F, Rimbach K, Eberle F, Eigenbrod T, Kaiser S, Holmes WM, Erdmann VA, Sprinzl M, Bec G, Keith G, Dalpke AH* and Helm M* (2012): Identification of modifications in microbial, native tRNA that suppress immunostimulatory activity. J Exp Med 209 (2): 225-233, doi 10.1084/jem.20111044

Interactions between bacteria and their host represent a full continuum from pathogenicity to mutualism. From an evolutionary perspective, host-bacteria relationships are no longer considered a two-component ecological system but rather a complex interactive network. Cystic fibrosis (CF) is characterized by defective mucociliary clearance associated with polymicrobial chronic airway infections. Those infections, leading to persistent inflammation and periodic episodes of acute pulmonary exacerbation, contribute to an irreversible decline in CF lung function. However, the link between bacterial infections and decline in CF lung function is not yet understood. We study CF lung microbiome aiming to answer different questions about CF microbiome resilience, antibiotic treatment effect and possible dysbiosis induced by exacerbation. In a runningproject we address the hypothesis that certain airway commensal bacteria might interfere with CF pathogens and thus exert rather beneficial effects. This work focuses on interactions of commensal bacteria with Pseudomonas aeruginosa within in vitro systems as well as microbiome and metagenomics studies from patients. Specifically we focus on short chain fatty acids produced by commensals and how these affect growth of pathogenic bacteria as well as inflammation. The projects combines in vitro work with a clinical study.

Selected publications

Tony-Odigie A, Dalpke1 AH, Boutin S, Yi B (2024): Airway commensal bacteria in cystic fibrosis inhibit the growth of P. aeruginosa via a released metabolite. Microbiol. Res., 283:127680, https://doi.org/10.1016/j.micres.2024.127680

Frey DL, Bridson C, Dittrich S, Graeber SY, Stahl M, Wege S, Herth F, Sommerburg O, Schultz C, Dalpke A*, Mall M*, Boutin S* (2022): Changes in microbiome dominance are associated with declining lung function and fluctuating inflammation in people with Cystic Fibrosis. Front Microbiol, 13:885822, doi:10.3389/fmicb.2022.885822

Tony-Odigie A, Wilke L, Boutin S, Dalpke AH and Yi B (2022):  Commensal bacteria in the cystic fibrosis airway microbiome reduce P. aeruginosa induced inflammation. Front Cell Infect Microbiol 12:824101, doi: 10.3389/fcimb.2022.824101

Metzger MI, Gräber SY, Stahl M, Sommerburg O, Mall MA, Dalpke AH and Boutin S (2021): A volatile and dynamic longitudinal microbiome is associated with less reduction in lung function in adolescents with cystic fibrosis. Front Cell Infect Microbiol, 11:763121. doi: 10.3389/fcimb.2021.763121

Frey DL*, Boutin S*, Dittrich S*, Graeber SY, Stahl M, Wege S, Herth F, Sommerburg O, Schultz C, Mall M, Dalpke A (2021): Relationship between airway dysbiosis, inflammation and lung function in adults with cystic fibrosis. J Cyst Fibr, S1569-1993(20):30954-1

Kolbe U, Yi B, Poth T, Saunders A, Boutin S, Dalpke A (2020): Early cytokine induction upon Pseudomonas aeruginosa infection in murine precision cut lung slices depends on sensing of bacterial viability. Front Immunol, 11: 598636. doi: 10.3389/fimmu.2020.598636

Boutin S, Graeber SY, Stahl M, Dittrich SA, Mall MA and Dalpke AH (2017): Chronic but not intermittent infection with Pseudomonas aeruginosa is associated with global changes of the lung microbiome in cystic fibrosis. Eur Respir J 50 (4): 1701086, doi: 10.1183/13993003.01086-2017

 

Supported by Mukoviszidose e.V.:

Links:

Mukoviszidose e.V.

https://www.muko.info/angebote/forschungsfoerderung/gefoerderte-projekte/#c2963

link to blog

blog.muko.info/koennen-normale-bakterien-des-rachenraums-infektionen-durch-pseudomonas-aeruginosa-positiv-beeinflussen/

Curriculum Vitae 
Since 2023PI, TRR156 „The skin as sensor and effector organ orchestrating local and systemic immunity”, project B05
Since 2022Full Professor (W3) for Medical Microbiology and Hygiene, Medical Director, Medical Microbiology and Hygiene, Dept. of Infectious Diseases, University Hospital Heidelberg
Since 2021PI, TRR319 “RMaP, RNA modifications and processing”, project A3
2019-2022Director, Institute of Med. Microbiology and Hygiene, Institute of Virology, Med. Faculty, Technical University Dresden
2015-2018Chairman of the Habilitation Committee I, Medical Faculty Heidelberg
2014-2018PI, German Center for Lung Research (DZL), TLRC Heidelberg
2012-2015Coordinator Teaching & Education Activities, DZIF, Heidelberg site
2011Consultant in microbiology, virology and epidemiology of infections
2011-2015Member of SFB 938 “Environment specific control of immunological reactivity"; project E
2008-2011Speaker of the Postgraduate Program "Differential activation and integration of signaling modules within the immune system"; postgraduate program of Baden-Württemberg
2007-2018Member of the "Hartmut Hoffmann-Berling International Graduate School of Molecular and Cellular Biology"
2006-2009Member of the SFB405 "Immunotolerance and its disturbances";
project B18
2006-2018Professor for Medical Microbiology and Infection and Immunity (W3),
Dept. of Medical Microbiology and Hygiene, University Heidelberg
2006Specialist in immunology ("Fachimmunologe DGfl", German Society for Immunology
2005-2006Group Leader, Dept. of Medical Microbiology and Hygiene,
University Heidelberg
2004-2008Member of the DFG priority programm SP1110 "Innate Immunity"
2004Habilitation, university lecturer for infection and immunity
Topic: Suppressor of Cytokine Signaling (SOCS) proteins as 
regulators of the activity of the innate immune system
1999-2004Post-doc and Research Assistant, Inst. of Medical Microbiology,
Philipps-University Marburg
1998-1999First-year resident, Kreis- und Stadtkrankenhaus Alfeld, Internal medicine, License to practice medicine („Approbation als Arzt“)
 1992-
 1998
Medical student, Georg-August University Göttingen

 

My group just recently moved to Heidelberg. Positions available and applications welcome

 

NameFunctionPhone +49 6221 56-
Dr. Lan-Sun Chenpostdoc34783
Andrew Tony-Odigiepostdoc310172
Ivaneiá Valeriano-NunesPhD Student 
Luisa BreitenbachPhD Student 
Paulina SchadPhD Student 
Mai WangPhD Student 
Suzan Jakobtechnician310065